Skip to main content

Table 1 Baseline Characteristics Of Patients Studied: Number (%) or Mean (SD) Values Are Shown

From: Real world long-term impact of intensive treatment on disease activity, disability and health-related quality of life in rheumatoid arthritis

  All Patients Patients Followed Over Three Or More Years Patients Followed Less Than Three Years
(n = 1693) (n = 752) (n = 941)
Gender, n (%) Female 1262 (75%) 579 (77%) 683 (73%)
Male 412 (24%) 165 (22%) 247 (26%)
Missing 19 (1%) 8 (1%) 11 (1%)
Ethnicity, n (%) Caucasian 1134 (67%) 540 (72%) 594 (63%)
Black African/Caribbean 209 (12%) 100 (13%) 109 (11%)
Asian/other background 128 (8%) 52 (7%) 76 (8%)
Not Stated 79 (5%) 27 (4%) 52 (6%)
Missing 143 (8%) 33 (4%) 110 (12%)
Age (years)   55 (16) 55 (15) 55 (14.7)
Disease Duration (years)   11 (10) 10 (10) 10 (9.7)
Tender Joint Counts (28 joints)   5.0 (6.6) 4.8 (6.0) 5.2 (6.5)
Swollen joint Counts (28 joints)   2.9 (4.7) 3.2 (3.9) 3.3 (4.3)
Erythrocyte Sedimentation Rate (mm/hr)   22 (21) 22 (21) 21.5 (22)
Patient Global Assessment (mm)   46 (28) 44 (27) 45 (28)
DAS28   3.83 (1.63) 3.79 (1.50) 3.85 (1.62)
Health Assessment Questionnaire   1.18 (0.83) 1.22 (0.86) 1.18 (0.83)
EQ5D-3 L   0.53 (0.34) 0.52 (0.33) 0.53 (0.34)